EUVIMED · CrossrefJournal
Journal of Human Immunity
ISSN 3065-8993 · Rockefeller University Press
Latest articles
Novel pathogenic FOXP3 variant in two unrelated families with IPEX syndrome
Genotype–phenotype analysis in 333 individuals with heterozygous variants in NFKB1
Type I IFN autoantibodies in three of seven Europeans with life-threatening Usutu virus infection
Truncating variants reveal functional divergence of the SAMD9 and SAMD9L paralogues
Familial TLR8 gain-of-function presenting as HLH with response to IFN-γ blockade
The rise in prevalence of autoantibodies neutralizing type I interferons reaches a plateau in centenarians
Still the one: Transcriptional control across leukopoiesis by SPI1/PU.1
MHC-II deficiency in a large Algerian cohort: Clinical, immunological, and genetic characterization
Severe dengue: Are type I interferon autoantibodies involved?
Australasian Society of Clinical Immunology and Allergy consensus statement on IEI molecular diagnosis
How I Treat: Haploinsufficiency of A20
Primary atopic disorders: Monogenic insights into immunity
Human germline biallelic loss-of-function OSMR variants cause severe allergic disease
Human ISG15 deficiency unveils impaired healing of ulcerations via type I interferon–mediated fibrosis
Inborn errors of immunity at school: How can we do better?
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts
From variants to answers: The evolution of genetic counseling in IEI
TLR7 mutations leading to enhanced TLR7 signaling in humans
Fatal H5N1 Avian Influenza Pneumonia Associated with Autoantibodies Neutralizing Type I Interferons
IgA defects in CVID lead to bacterial translocation, increased serum γ-interferon, and BAFF
Lymphoproliferation in inborn errors of immunity: From challenging diagnosis to histologic revision
Extended clinical phenotypes and long-term outcomes of phosphoglucomutase-3 deficiency
Auto-Abs against type I IFNs: Strong, common, and global determinants of severe arboviral diseases
Neurodegenerative Complications in XLA
Re-evaluation of the contribution of TNFRSF13B variants to antibody deficiency
Incomplete penetrance in inborn errors of immunity: A skeleton in the closet—The sequel
Cartilage-hair hypoplasia: A comprehensive review
The seven enigmas of SARS-CoV-2: From the past to the future
Inborn errors of immunity: Manifestation, treatment, and outcome—an ESID registry 1994–2024 report on 30,628 patients
Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging
EUVIMED